|
Kroning, R; Jones, J A; Hom, D K et al. (1995) Enhancement of drug sensitivity of human malignancies by epidermal growth factor. Br J Cancer 72:615-9
|
|
Eastman, A; Barry, M A (1992) The origins of DNA breaks: a consequence of DNA damage, DNA repair, or apoptosis? Cancer Invest 10:229-40
|
|
Jennerwein, M M; Eastman, A; Khokhar, A R (1991) The role of DNA repair in resistance of L1210 cells to isomeric 1,2-diaminocyclohexaneplatinum complexes and ultraviolet irradiation. Mutat Res 254:89-96
|
|
Eastman, A (1991) Analysis and quantitation of the DNA damage produced in cells by the cisplatin analog cis-[3H]dichloro(ethylenediamine)platinum (II). Anal Biochem 197:311-5
|
|
Sheibani, N; Eastman, A (1990) Analysis of various mRNA potentially involved in cisplatin resistance of murine leukemia L1210 cells. Cancer Lett 52:179-85
|
|
Barry, M A; Behnke, C A; Eastman, A (1990) Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 40:2353-62
|
|
Sorenson, C M; Barry, M A; Eastman, A (1990) Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst 82:749-55
|
|
Jennerwein, M M; Eastman, A; Khokhar, A (1989) Characterization of adducts produced in DNA by isomeric 1,2-diaminocyclohexaneplatinum(II) complexes. Chem Biol Interact 70:39-49
|
|
Sheibani, N; Jennerwein, M M; Eastman, A (1989) DNA repair in cells sensitive and resistant to cis-diamminedichloroplatinum(II): host cell reactivation of damaged plasmid DNA. Biochemistry 28:3120-4
|
|
Sorenson, C M; Eastman, A (1988) Mechanism of cis-diamminedichloroplatinum(II)-induced cytotoxicity: role of G2 arrest and DNA double-strand breaks. Cancer Res 48:4484-8
|
Showing the most recent 10 out of 19 publications
